BCTX

NASD BriaCell Therapeutics Corp
Oct 10, 2026 · 3:33 AM ET EOD Market Closed

$3.91 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.91, $0.09 below the day’s high of $4.00

YTD change
-45.01%
vs 20-day SMA
-2.72%
vs 200-day SMA
-5.57%

Price ranges

Previous day
$3.91 $4.00
open $3.95 close $3.91
-$0.04 (-1.01%)
Today
$3.91 $4.00
$3.91
Past week
$3.87 $4.33
from $4.11 now $3.91
-$0.20 (-4.87%)
Past month
$3.48 $4.43
from $3.60 now $3.91
+$0.31 (+8.61%)
This year
$2.60 $12.10
from $7.11 now $3.91
-$3.20 (-45.01%)

Price & Performance

-0.37 (-8.64%) / 6M

$2.59$3.32$4.04$4.77Apr 10Jul 13Oct 9

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 99.8% away from all-time highs of $1,870.50
  • BCTX is down 45% since the beginning of the year
  • BCTX is down 69% over the past 12 months
  • BCTX is up 9% over the past 1 month
  • 9% of all BCTX investors are betting against BCTX

BCTX reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -68.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.99
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $4.9M
Beta 1.16

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$22.8M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $34.0M

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMTâ„¢ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $414.87 +1.82%
MRNA Moderna, Inc. $225.00 +14.21%
RVMD Revolution Medicines, Inc. $189.76 +0.87%
ROIV Roivant Sciences Ltd. $35.44 +3.60%
BNTX BioNTech SE Sponsored ADR $96.96 +5.32%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.